Literature DB >> 3533303

Elimination of metabolic cooperation by glycyrrhetinic acid, an anti-tumor promoter, in cultured Chinese hamster cells.

H Tsuda, H Okamoto.   

Abstract

The effect of glycyrrhetinic acid (GA) on the metabolic cooperation between 6-thioguanine-resistant (6TGR) and sensitive (6TGS) Chinese hamster V79 H3 cells, was investigated. Because GA has been reported to inhibit strongly tumor formation in mouse skin induced by 7,12-dimethylbenz[a]anthracene (DMBA) plus teleocidin or DMBA plus 12-O-tetradecanoylphorbol-13-acetate (TPA), we expected that GA might restore the metabolic cooperation inhibited by TPA. The results were contrary to our expectations. GA (20-50 microM) acted cumulatively with TPA to inhibit metabolic cooperation even more, and GA (20-75 microM), by itself, was found to be a strong inhibitor of metabolic cooperation. GA was not mutagenic at the concentrations examined (0-100 microM).

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3533303     DOI: 10.1093/carcin/7.11.1805

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  3 in total

1.  Glycyrrhizin as a promoter of the late signal transduction for interleukin-2 production by splenic lymphocytes.

Authors:  Y H Zhang; K Isobe; F Nagase; T Lwin; M Kato; M Hamaguchi; T Yokochi; I Nakashima
Journal:  Immunology       Date:  1993-08       Impact factor: 7.397

2.  One-step Conjugation of Glycyrrhetinic Acid to Cationic Polymers for High-performance Gene Delivery to Cultured Liver Cell.

Authors:  Yue Cong; Bingyang Shi; Yiqing Lu; Shihui Wen; Roger Chung; Dayong Jin
Journal:  Sci Rep       Date:  2016-02-23       Impact factor: 4.379

3.  Pre-clinical development as microbicide of zinc tetra-ascorbo-camphorate, a novel terpenoid derivative: potent in vitro inhibitory activity against both R5- and X4-tropic HIV-1 strains without significant in vivo mucosal toxicity.

Authors:  Héla Saïdi; Mohammad-Ali Jenabian; Bernard Gombert; Charlotte Charpentier; Aurèle Mannarini; Laurent Bélec
Journal:  AIDS Res Ther       Date:  2008-06-03       Impact factor: 2.250

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.